A study exploring critical pathways in clear cell renal cell carcinoma

被引:13
作者
Zeng, Zisan [1 ]
Que, Tengcheng [2 ]
Zhang, Jiange [3 ]
Hu, Yanling [4 ,5 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Radiol, Nanning 530021, Guangxi, Peoples R China
[2] Forestry Bur Guangxi, Wild Anim Rescue Ctr, Nanning 530021, Guangxi, Peoples R China
[3] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol, Nanning 530021, Guangxi, Peoples R China
[4] Guangxi Med Univ, Med Sci Res Ctr, Nanning 530021, Guangxi, Peoples R China
[5] Guangxi Med Univ, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
clear cell renal cell carcinoma; pathway analysis; meta-analyis; gene expression; SET ENRICHMENT ANALYSIS; TRANS-RETINOIC ACID; 13-CIS-RETINOIC ACID; INTERFERON ALPHA-2A; HEREDITARY LEIOMYOMATOSIS; PHASE-II; EXPRESSION; GENE; CANCER; TRIAL;
D O I
10.3892/etm.2013.1392
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results.
引用
收藏
页码:121 / 130
页数:10
相关论文
共 60 条
  • [1] Randomized phase II/III trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma:: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)
    Aass, N
    De Mulder, PHM
    Mickisch, GHJ
    Mulders, P
    van Oosterom, AT
    van Poppel, H
    Fossa, SD
    de Prijck, L
    Sylvester, RJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4172 - 4178
  • [2] [Anonymous], BIOMETRICS
  • [3] [Anonymous], USING CATEGORIES MOD
  • [4] All-trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
    Asou, Norio
    [J]. INTERNAL MEDICINE, 2007, 46 (02) : 91 - 93
  • [5] Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma:: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
    Atzpodien, J.
    Kirchner, H.
    Rebmann, U.
    Soder, M.
    Gertenbach, U.
    Siebels, M.
    Roigas, J.
    Raschke, R.
    Salm, S.
    Schwindl, B.
    Mueller, S. C.
    Hauser, S.
    Leiber, C.
    Huland, E.
    Heinzer, H.
    Siemer, S.
    Metzner, B.
    Heynemann, H.
    Fornara, P.
    Reitz, M.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (04) : 463 - 469
  • [6] The significance of cancer cell expression of the chemokine receptor CXCR4
    Balkwill, F
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) : 171 - 179
  • [7] Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma
    Baysal, BE
    Ferrell, RE
    Willett-Brozick, JE
    Lawrence, EC
    Myssiorek, D
    Bosch, A
    van der Mey, A
    Taschner, PEM
    Rubinstein, WS
    Myers, EN
    Richard, CW
    Cornelisse, CJ
    Devilee, P
    Devlin, B
    [J]. SCIENCE, 2000, 287 (5454) : 848 - 851
  • [8] Phase 1/2 clinical trial of interferon α2b and weekly liposome-encapsulated all-trans retinoic acid in patients with advanced renal cell carcinoma
    Boorjian, Stephen A.
    Milowsky, Matthew I.
    Kaplan, Jodi
    Albert, Martin
    Cobham, Marta Vallee
    Coll, Deirdre M.
    Mongan, Nigel P.
    Shelton, Gary
    Petrylak, Daniel
    Gudas, Lorraine J.
    Nanus, David M.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2007, 30 (06) : 655 - 662
  • [9] Brannon A Rose, 2010, Genes Cancer, V1, P152
  • [10] CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
    Burger, JA
    Kipps, TJ
    [J]. BLOOD, 2006, 107 (05) : 1761 - 1767